Literature DB >> 26461966

Anticoagulation therapy: Sulodexide reduces the risk of recurrent venous thromboembolism.

Irene Fernández Ruiz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26461966     DOI： 10.1038/nrcardio.2015.163

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Sulodexide for the Prevention of Recurrent Venous Thromboembolism: The Sulodexide in Secondary Prevention of Recurrent Deep Vein Thrombosis (SURVET) Study: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Giuseppe M Andreozzi; Angelo A Bignamini; Giovanni Davì; Gualtiero Palareti; Jiří Matuška; Martin Holý; Katarzyna Pawlaczyk-Gabriel; Andrej Džupina; German Y Sokurenko; Yury P Didenko; Laurentia D Andrei; Gianfranco Lessiani; Adriana Visonà
Journal:  Circulation       Date:  2015-09-25       Impact factor: 29.690
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.